Home > Income Statement > OXYGENTA PHARMACEUTICAL

OXYGENTA PHARMACEUTICAL
Revenue

    Back to Income Statement
OXYGENTA PHARMACEUTICAL is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for OXYGENTA PHARMACEUTICAL
Please provide your vote to see the results

OXYGENTA PHARMACEUTICAL Last 5 Year Revenue History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹40 Cr₹31 Cr₹6,052,481 Cr₹52 Cr₹14 Cr

What is the latest Revenue of OXYGENTA PHARMACEUTICAL ?

The latest Revenue ratio of OXYGENTA PHARMACEUTICAL is ₹40 Cr based on Mar2025 Standalone results.
Year Revenue
Mar2025₹40 Cr
Mar2024₹31 Cr
Mar2023₹6,052,481 Cr
Mar2022₹52 Cr
Mar2021₹14 Cr

How is Revenue of OXYGENTA PHARMACEUTICAL Trending?

Years Revenue % Change
Mar2025 ₹40 Cr
27.93
Mar2024 ₹31 Cr
-100.00
Mar2023 ₹6,052,481 Cr
11,633,245.46
Mar2022 ₹52 Cr
279.32
Mar2021 ₹14 Cr -

Compare Revenue of peers of OXYGENTA PHARMACEUTICAL

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL ₹185.3 Cr 4.8% -9.5% -58.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹440,794.0 Cr 1.7% -2.3% 8% Stock Analytics
DIVIS LABORATORIES ₹178,956.0 Cr 2% -2.2% 1.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹149,820.0 Cr -1.8% -0.1% 36.7% Stock Analytics
CIPLA ₹109,370.0 Cr -2% -3.3% -9.9% Stock Analytics
DR REDDYS LABORATORIES ₹106,133.0 Cr -0.6% -3.8% -6.9% Stock Analytics


OXYGENTA PHARMACEUTICAL Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL

4.8%

-9.5%

-58.3%

SENSEX

1.7%

2.1%

-6%


You may also like the below Video Courses